Sort
27,075 grants matching “cholesterol”
Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue
$975,889Giuseppina Tesco · Tufts University Boston · R01 · FY2024 · AG
Regulation of lipid metabolism by miRNAs
$975,803Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
The Human Life Course and the Biodemography of Aging
$975,411Michael Douglas Gurven · University Of California Santa Barbara · R01 · FY2014 · AG
Preclinical Development of Oxy200 for the Treatment of Osteoporosis
$975,009Frank Stappenbeck · Max Biopharma, Inc. · R44 · FY2019 · AG
Preclinical Development of Oxy200 for the Treatment of Osteoporosis
$975,009Frank Stappenbeck · Max Biopharma, Inc. · R44 · FY2018 · AG
Metabolic Influences on Complex Tumor Neighborhoods
$975,000M. Celeste Simon · University Of Pennsylvania · R35 · FY2025 · CA
Clinical Investigations of Inborn Errors of Metabolism
$974,404Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology
$974,324Arvin Garg · Boston Medical Center · R01 · FY2019 · HL
Metabolic Effects of Newer Antipsychotics in Older Pts
$973,968Dilip V Jeste · Veterans Medical Research Fdn/San Diego · R01 · FY2008 · MH
THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL
$973,725Barry Davis · University Of Texas Hlth Sci Ctr Houston · N01 · FY2012 · HL
Minerals in Nutrition and Development
$972,718Rajini Rao · Johns Hopkins University · UC2 · FY2024 · HD
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
$972,425Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2015 · HG
THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL
$971,242Barry Davis · University Of Texas Hlth Sci Ctr Houston · N01 · FY2011 · HL
Development and Use of Network Infrastructure for High-Throughput GWA Studies
$970,601Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2007 · HG
Proof of Extended Absorption of Liothyronine from PolyZincLiothyronine (PZL) inHumans
$970,548Thomas Piccariello · Synthonics, Inc. · R44 · FY2019 · DK
Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury
$969,488Andrew Defilippis · Vanderbilt University Medical Center · R01 · FY2021 · HL
Targeting Castration Resistant Prostate Cancer via Potent Inhibition of Signaling Lipids
$969,204Salma Kaochar · Baylor College Of Medicine · R01 · FY2025 · CA
Prospective studies on Parkinson's disease
$968,834Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Acute Hepatitis C Infection in Young Injectors
$968,688Kimberly Page · University Of California, San Francisco · R01 · FY2010 · DA
Mechanism Of Cholesterol Accumulation In Human Atherosclerosis
$968,670Howard S Kruth · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION
$968,432University Of Cincinnati · P01 · FY2000 · DK
Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV
$967,884Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2013 · HL
Actin assembly and clathrin-mediated endocytosis in yeast and mammals
$967,144David G. Drubin · University Of California Berkeley · R35 · FY2016 · GM
Development of recombinant Lecithin Cholesterol Acyltransferase as a therapeutic
$965,897Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$965,587Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA